Tak Wah Mak

This inventor holds 32 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Immunotherapy Research. Top assignees: University Health Network, The Ontario Cancer Institute, Amgen Canada Inc.. Active years: 1987-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tak Wah Mak. Retrieved from https://idiyas.com/inventor/tak-wah-mak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 5)

% Patents Active = 68.8

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.0

ph-index = 12

Forward Citations = 334(Granted Patents)

Company Filing History:

12 out of 312

University Health Network

patents

11 out of 26

The Ontario Cancer Institute

Casi Pharmaceuticals, Inc.

patents

6. 1 out of 25

Hospital for Special Surgery

patents

7. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1987-2024

Loading Chart...

Areas of Expertise:

Polo-Like Kinase 4

TTK Protein Kinase

Toso Modulation

Autoimmune Disease

B7RP-2 Fusion Protein

Hodgkin Cell Growth

CD45 Disruption

Transgenic Mice

CTLA-4 Receptor

Interleukin-2 Receptor

T Cell Specific

Immune Response Polypeptides

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109215 - Combination therapies for inhibition of polo-like kinase 4 (2024-10-08),

2. 11766437 - Combination therapies for inhibition of TTK protein kinase (2023-09-26),

3. 10822388 - Methods and compositions for modulating toso activity (2020-11-03),

4. 10533222 - Methods and compositions for detection of targets for autoimmune disease (2020-01-14),

5. 10024844 - Identification of an inhibitor of iRhom1 or an inhibitor of iRhom2 (2018-07-17),

6. 9670265 - Methods and compositions for modulating toso activity (2017-06-06),

7. 9624289 - Methods and compositions for modulating Toso activity (2017-04-18),

8. 9493561 - Antibodies to Toso (2016-11-15),

9. 9321824 - Methods and compositions for modulating Toso activity (2016-04-26),

10. 9228006 - Methods and compositions for modulating Toso activity (2016-01-05),

11. 9132138 - Method for the treatment of multiple sclerosis (2015-09-15),

12. 8309083 - Polypeptides involved in immune response (2012-11-13),

13. 7708993 - Polypeptides involved in immune response (2010-05-04),

14. 7482325 - Downregulation of immune response by administering B7RP-2 fusion protein (2009-01-27),

15. 7312024 - Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth (2007-12-25),

Title: Inventor Tak Wah Mak

Introduction: Tak Wah Mak is a renowned inventor based in Toronto, Canada, known for his groundbreaking contributions to the field of biomedicine and genetics.

Latest Patents: Tak Wah Mak holds several patents in the areas of immunology, oncology, and molecular biology, showcasing his innovative approach to solving complex medical challenges.

Career Highlights: With a distinguished career spanning several decades, Tak Wah Mak has made significant advancements in understanding the immune system and developing novel therapies for various diseases.

Collaborations: Throughout his career, Tak Wah Mak has collaborated with leading researchers, scientists, and pharmaceutical companies globally, further solidifying his reputation as a pioneering inventor in the medical field.

Conclusion: Tak Wah Mak's relentless pursuit of innovation and his commitment to improving human health have established him as a prominent figure in the world of biomedicine and genetics.

Profile summary based on public USPTO records.